Domov › Rakovina pľúc › Pennsylvania › Pittsburgh
Klinické štúdie Rakovina pľúc v meste Pittsburgh, PA
23 štúdií pre Rakovina pľúc hľadá účastníkov v zariadeniach v meste Pittsburgh a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Prebieha náborFáza 3
- Bryn Mawr Hospital, Bryn Mawr · 11 míľ odtiaľ
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Prebieha náborFáza 1/2
- Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- UPMC-Saint Margaret, Pittsburgh
- UPMC-Mercy Hospital, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- a 11 ďalších
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Prebieha náborFáza 3
- Bryn Mawr Hospital, Bryn Mawr · 11 míľ odtiaľ
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
Prebieha nábor
- UPMC Hillman Cancer Center, Pittsburgh
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Prebieha náborFáza 3
- UPMC Hillman Cancer Center, Pittsburgh
- Bryn Mawr Hospital, Bryn Mawr · 11 míľ odtiaľ
- UPMC Hillman Cancer Center - Monroeville, Monroeville · 11 míľ odtiaľ
- a 1 ďalších
A Registry for People With Lung Cancer
Prebieha náborObservačná štúdia
- ALLEGHENY HEALTH NETWORK (Data Collection Only), Pittsburgh
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Prebieha náborFáza 2
- Research Site, Pittsburgh
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Prebieha náborFáza 2/3
- West Penn Allegheny Health, Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- Allegheny Health Network, Pittsburgh
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Prebieha náborFáza 1/2
- UPMC Hillman Cancer Center, Pittsburgh
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- UPMC Hillman Cancer Center, Pittsburgh
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Allegheny Cancer Center, Pittsburgh
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Prebieha náborFáza 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Prebieha náborFáza 1
- UPMC Hillman Cancer Center, Pittsburgh
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Prebieha náborFáza 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Prebieha náborFáza 2
- Allegheny General Hospital, Natrona Heights · 19 míľ odtiaľ
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Prebieha náborFáza 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- UPMC-Saint Margaret, Pittsburgh
- UPMC-Mercy Hospital, Pittsburgh
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- a 11 ďalších
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- UPMC-Saint Margaret, Pittsburgh
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- a 9 ďalších
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Prebieha náborObservačná štúdia
- Allegheny Health Network, Pittsburgh
Detection of Genetic Markers of Lung Cancer
Prebieha náborObservačná štúdia
- Hillman Cancer Center, Pittsburgh
Štúdie Rakovina pľúc v iných mestách
- Houston, TX78 štúdií
- Boston, MA62 štúdií
- New York City, NY60 štúdií
- Los Angeles, CA45 štúdií
- Arlington, VA41 štúdií
- Washington, DC41 štúdií
- Chicago, IL41 štúdií
- Baltimore, MD40 štúdií
- Nashville, TN40 štúdií
- St. Louis, MO39 štúdií
- Columbus, OH37 štúdií
- Philadelphia, PA36 štúdií
Iné štúdie v Pittsburgh
- Nemalobunkový karcinóm pľúc48 štúdií
- Rakovina (všetky typy)41 štúdií
- Rakovina prsníka39 štúdií
- Kolorektálny karcinóm32 štúdií
- Metastatická rakovina31 štúdií
- Melanóm31 štúdií
- Rakovina vaječníkov30 štúdií
- Rakovina endometria23 štúdií
- Rakovina prostaty23 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku22 štúdií
- Cievna mozgová príhoda22 štúdií
- Depresia22 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.